Ritholtz Wealth Management Laboratory Corp Of America Holdings Transaction History

Ritholtz Wealth Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 18, 2022	SELL	$204.81 - $262.19 $36,456 - $46,669	-178 Reduced 7.94%	2,063 $423,000
Q2 2022 Jul 15, 2022	BUY	$213.86 - $277.87 $28,229 - $36,678	132 Added 6.26%	2,241 $525,000
Q1 2022 Apr 14, 2022	BUY	$259.82 - $298.18 $91,456 - $104,959	352 Added 20.03%	2,109 $556,000
Q4 2021 Jan 18, 2022	BUY	$271.6 - $314.21 $172,194 - $199,209	634 Added 56.46%	1,757 $552,000
Q3 2021 Oct 14, 2021	BUY	$274.82 - $308.34 $308,622 - $346,265	1,123 New	1,123 $316,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.6B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Ritholtz Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Ritholtz Wealth Management with notifications on news.